Neurocrine (NBIX)
NASDAQ:NBIX
Holding NBIX?
Track your performance easily

Neurocrine (NBIX) Financial Statements

1,264 Followers

Neurocrine Financial Overview

Neurocrine's market cap is currently ―. The company's EPS TTM is $3.31; its P/E ratio is 36.21; Neurocrine is scheduled to report earnings on October 29, 2024, and the estimated EPS forecast is $1.54. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 590.20M$ 515.30M$ 515.20M$ 498.80M$ 452.70M
Gross Profit$ 581.00M$ 507.80M$ 506.70M$ 487.60M$ 441.20M
EBIT$ 98.60M$ 35.60M$ 199.30M$ 116.70M$ 122.90M
EBITDA$ 113.00M$ 41.80M$ 205.00M$ 122.40M$ 128.20M
Net Income Common Stockholders$ 65.00M$ 43.40M$ 147.70M$ 83.10M$ 95.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.04B$ 1.21B$ 1.03B$ 1.10B$ 976.70M
Total Assets$ 3.31B$ 3.47B$ 3.25B$ 2.85B$ 2.61B
Total Debt$ 256.20M$ 375.70M$ 428.40M$ 255.80M$ 258.80M
Net Debt$ -782.70M$ -834.90M$ -603.20M$ -839.30M$ -717.90M
Total Liabilities$ 795.80M$ 1.09B$ 1.02B$ 846.10M$ 760.10M
Stockholders Equity$ 2.51B$ 2.39B$ 2.23B$ 2.00B$ 1.85B
Cash Flow-
Free Cash Flow$ 53.00M$ 119.10M$ 118.10M$ 204.40M$ 172.80M
Operating Cash Flow$ 64.60M$ 130.30M$ 123.50M$ 212.00M$ 179.60M
Investing Cash Flow$ -28.20M$ -55.00M$ -201.80M$ -97.30M$ -125.90M
Financing Cash Flow$ -293.00M$ 69.90M$ 35.40M$ 18.80M$ 2.90M
Currency in USD

Neurocrine Earnings and Revenue History

Neurocrine Debt to Assets

Neurocrine Cash Flow

Neurocrine Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis